Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Neuromuscular Junction And Blockade

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...

The Spindle Assembly Checkpoint

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...

What is the Immune System?

What is the Immune System?

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Humoral Immune Responses

Humoral Immune Responses

Group Therapy

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarker.

British journal of cancer·2026

Same author

Real-world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study.

International journal of cancer·2026

Same author

Caspase-activation powers anti-Desmoglein 3-induced acantholysis in human epidermis.

Cell death discovery·2026

Same author

Cytokine-induced senescence in tumors is based on sustained activation of STAT1- and NFκB-dependent gene regulatory signatures.

GeroScience·2026

Same author

Vδ1 T-cell subset appears to be responsive to PD-1 blockade therapy and is associated with survival in melanoma.

Journal for immunotherapy of cancer·2026

Same author

Immune cell senescence drives responsiveness to immunotherapy in melanoma.

Molecular cancer·2025

Same journal

Tamoxifen-driven neutrophil reprogramming protects from pulmonary Granulibacter bethesdensis infection in chronic granulomatous disease.

The Journal of allergy and clinical immunology·2026

Same journal

Clinical and transcriptomic characterization of mixed granulocytic COPD phenotype.

The Journal of allergy and clinical immunology·2026

Same journal

Dupilumab outcomes in pediatric asthma by early eosinophil status: post hoc analysis of VOYAGE/EXCURSION.

The Journal of allergy and clinical immunology·2026

Same journal

Maternal antibiotic exposure alters the newborn metabolomic profile and increases the risk of respiratory infections in offspring: a 13-year longitudinal birth cohort study.

The Journal of allergy and clinical immunology·2026

Same journal

Selective Elimination of Mast Cells via Siglec-6-Targeted Nanodelivery of Drug Payload.

The Journal of allergy and clinical immunology·2026

Same journal

Loss of epidermal miR-149 sensitizes to skin inflammation.

The Journal of allergy and clinical immunology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 12, 2026

Study of the DNA Damage Checkpoint using Xenopus Egg Extracts

Study of the DNA Damage Checkpoint using Xenopus Egg Extracts

Published on: November 5, 2012

Immune checkpoint blockade therapy.

Thomas Wieder¹, Thomas Eigentler¹, Ellen Brenner¹

¹Department of Dermatology, Eberhard Karls University, Tübingen, Germany.

The Journal of Allergy and Clinical Immunology

|March 30, 2018

Summary

This summary is machine-generated.

Immune checkpoint inhibitors like CTLA-4 and PD-1 block cancer immune suppression, restoring T-cell activity. However, this therapy can cause autoimmune diseases and is very expensive.

Keywords:

Cytokine-induced senescence T helper cells autoimmunity cytotoxic T lymphocytes interferon tumor dormancy tumor eradication

More Related Videos

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy

Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy

Published on: June 25, 2013

Related Experiment Videos

Last Updated: Feb 12, 2026

Study of the DNA Damage Checkpoint using Xenopus Egg Extracts

Study of the DNA Damage Checkpoint using Xenopus Egg Extracts

Published on: November 5, 2012

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy

Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy

Published on: June 25, 2013

Area of Science:

Immunology
Oncology
Pharmacology

Background:

Immune checkpoints regulate T-cell activation, with inhibitory molecules like CTLA-4 and PD-1 crucial for preventing self-damage.
Dysregulation of immune checkpoints contributes to cancer immune evasion.
Current cancer therapies often focus on enhancing immune activation, but checkpoint blockade targets immune suppression.

Purpose of the Study:

To elucidate the mechanism of immune checkpoint blockade therapy in cancer.
To highlight the dual role of immune checkpoints in immune regulation and cancer.
To discuss the implications of immune checkpoint blockade for cancer treatment and patient outcomes.

Main Methods:

Review of existing literature on immune checkpoints and cancer immunotherapy.
Analysis of the mechanisms by which CTLA-4 and PD-1 blockade affect T-cell responses.
Examination of clinical applications and outcomes of immune checkpoint inhibitors in various cancers.

Main Results:

Inhibiting CTLA-4 or PD-1 reactivates exhausted T-cells, enhancing anti-tumor immunity.
Checkpoint blockade has shown significant efficacy in metastatic solid cancers, including melanoma, lung, and renal cancers.
The therapy can induce organ-specific autoimmune diseases due to the activation of self-reactive T-cells.

Conclusions:

Immune checkpoint blockade represents a paradigm shift in cancer therapy by targeting immune suppression.
While effective, the therapy presents challenges including autoimmune side effects and high cost.
Further research is needed to optimize treatment strategies and mitigate adverse effects.